User menu

Management of salivary gland tumors

Bibliographic reference Andry, G. ; Hamoir, Marc ; Locati, L.D. ; Licitra, L. ; Langendijk, J.A.. Management of salivary gland tumors . In: Expert Review of Anticancer Therapy, Vol. 12, no.9, p. 1161-1168 (2012)
Permanent URL http://hdl.handle.net/2078.1/125327
  1. Chandana Sreenivasa R, Conley Barbara A, Salivary gland cancers: current treatments, molecular characteristics and new therapies, 10.1586/14737140.8.4.645
  2. Wening, Atlas Head Neck Pathol., 541 (2008)
  3. Sobin LH, Gospodarowics MK, Wittekind CH.TNM Classification of Malignant Tumours (7th Edition). UICC, 54–57 (2009).
  4. Boukheris H., Curtis R. E., Land C. E., Dores G. M., Incidence of Carcinoma of the Major Salivary Glands According to the WHO Classification, 1992 to 2006: A Population-Based Study in the United States, 10.1158/1055-9965.epi-09-0638
  5. Muenscher A., Diegel T., Jaehne M., Ussmüller J., Koops S., Sanchez-Hanke M., Benign and malignant salivary gland diseases in children, 10.1016/j.anl.2008.07.006
  6. Ishibashi Mana, Fujii Shinya, Kawamoto Katsuyuki, Nishihara Keisuke, Matsusue Eiji, Kodani Kazuhiko, Kaminou Toshio, Ogawa Toshihide, The ability to identify the intraparotid facial nerve for locating parotid gland lesions in comparison to other indirect landmark methods: evaluation by 3.0 T MR imaging with surface coils, 10.1007/s00234-010-0718-1
  7. Spiro Jeffrey D., Spiro Ronald H., Cancer of the Parotid Gland: Role of 7th Nerve Preservation, 10.1007/s00268-003-7112-7
  8. Wittekindt, Recurrent Pleomorphic Adenoma of the Parotid Gland: Analysis of 108 Consecutive Patients (2007)
  9. Shekar Kishore, Singh Mark, Godden Daryl, Puxeddu Roberto, Brennan Peter A., Recent advances in the management of salivary gland disease, 10.1016/j.bjoms.2009.07.006
  10. Nouraei S. A. R., Ferguson M. S., Clarke P. M., Sandison A., Sandhu G. S., Michaels L., Rhys-Evans P., Metastasizing Pleomorphic Salivary Adenoma, 10.1001/archotol.132.7.788
  11. Salivary Gland Disorders and Diseases: Diagnosis and Management, 330 (2011)
  12. Bhattacharyya Neil, Fried Marvin P., Nodal Metastasis in Major Salivary Gland Cancer : Predictive Factors and Effects on Survival, 10.1001/archotol.128.8.904
  13. Razfar Ali, Heron Dwight E., Branstetter Barton F., Seethala Raja R., Ferris Robert L., Positron emission tomography-computed tomography adds to the management of salivary gland malignancies, 10.1002/lary.20829
  14. Carrillo José F., Maldonado Federico, Carrillo Liliana C., Ramirez-Ortega Margarita C, Pizano Juan G. Gómez, Melo C., Chanona José G, Luna-Ortiz K., Ocaña Luis F. Oñate, Prognostic factors in patients with minor salivary gland carcinoma of the oral cavity and oropharynx, 10.1002/hed.21641
  15. Pohar Surjeet, Gay Hiram, Rosenbaum Paula, Klish Darren, Bogart Jeffrey, Sagerman Robert, Hsu Jack, Kellman Robert, Malignant parotid tumors: Presentation, clinical/pathologic prognostic factors, and treatment outcomes, 10.1016/j.ijrobp.2004.04.052
  16. Terhaard Chris H.J., Lubsen Herman, Rasch Coen R.N., Levendag Peter C., Kaanders Hans H.À.M., Tjho-Heslinga Reineke E., van Den Ende Piet L.A., Burlage Fred, The role of radiotherapy in the treatment of malignant salivary gland tumors, 10.1016/j.ijrobp.2004.03.018
  17. Tanvetyanon Tawee, Qin Dahui, Padhya Tapan, McCaffrey Judith, Zhu Weiwei, Boulware David, DeConti Ronald, Trotti Andy, Outcomes of Postoperative Concurrent Chemoradiotherapy for Locally Advanced Major Salivary Gland Carcinoma, 10.1001/archoto.2009.70
  18. Tanvetyanon Tawee, Padhya Tapan, McCaffrey Judith, Zhu Weiwei, Boulware David, DeConti Ronald, Trotti Andrea, Prognostic Factors for Survival After Salvage Reirradiation of Head and Neck Cancer, 10.1200/jco.2008.20.0691
  19. Schoenfeld Jonathan D., Sher David J., Norris Charles M., Haddad Robert I., Posner Marshall R., Balboni Tracy A., Tishler Roy B., Salivary Gland Tumors Treated With Adjuvant Intensity-Modulated Radiotherapy With or Without Concurrent Chemotherapy, 10.1016/j.ijrobp.2010.09.042
  20. Mendenhall William M., Morris Christopher G., Amdur Robert J., Werning John W., Villaret Douglas B., Radiotherapy alone or combined with surgery for salivary gland carcinoma, 10.1002/cncr.21083
  21. Chen Allen M., Bucci M. Kara, Quivey Jeanne M., Garcia Joaquin, Eisele David W., Fu Karen K., Long-term outcome of patients treated by radiation therapy alone for salivary gland carcinomas, 10.1016/j.ijrobp.2006.06.050
  22. Huber Peter E, Debus Juergen, Latz Detlev, Zierhut Dietmar, Bischof Marc, Wannenmacher Michael, Engenhart-Cabillic Rita, Radiotherapy for advanced adenoid cystic carcinoma: neutrons, photons or mixed beam?, 10.1016/s0167-8140(00)00273-5
  23. Pommier Pascal, Liebsch Nobert J., Deschler Daniel G., Lin Derrick T., McIntyre James F., Barker Fred G., Adams Judy A., Lopes Vrishali V., Varvares Mark, Loeffler Jay S., Chan Annie W., Proton Beam Radiation Therapy for Skull Base Adenoid Cystic Carcinoma, 10.1001/archotol.132.11.1242
  24. Schulz-Ertner Daniela, Nikoghosyan Anna, Didinger Bernd, Münter Marc, Jäkel Oliver, Karger Christian P., Debus Juergen, Therapy strategies for locally advanced adenoid cystic carcinomas using modern radiation therapy techniques, 10.1002/cncr.21158
  25. Laurie Scott A, Ho Alan L, Fury Matthew G, Sherman Eric, Pfister David G, Systemic therapy in the management of metastatic or locally recurrent adenoid cystic carcinoma of the salivary glands: a systematic review, 10.1016/s1470-2045(10)70245-x
  26. Haddad Robert, Colevas A.Dimitrios, Krane Jeffrey F, Cooper Dennis, Glisson Bonnie, Amrein Philip C, Weeks Linda, Costello Rosemary, Posner Marshall, Herceptin in patients with advanced or metastatic salivary gland carcinomas. A phase II study, 10.1016/s1368-8375(03)00097-6
  27. Jaspers Heidy C.J., Verbist Berit M., Schoffelen Rafke, Mattijssen Vera, Slootweg Piet J., van der Graaf Winette T.A., van Herpen Carla M.L., Androgen Receptor–Positive Salivary Duct Carcinoma: A Disease Entity With Promising New Treatment Options, 10.1200/jco.2010.32.8351
  28. Rugo Hope S., Herbst Roy S., Liu Glenn, Park John W., Kies Merrill S., Steinfeldt Heidi M., Pithavala Yazdi K., Reich Steven D., Freddo James L., Wilding George, Phase I Trial of the Oral Antiangiogenesis Agent AG-013736 in Patients With Advanced Solid Tumors: Pharmacokinetic and Clinical Results, 10.1200/jco.2005.04.192
  29. Argiris Athanassios, Ghebremichael Musie, Burtness Barbara, Axelrod Rita S., Deconti Ronald C., Forastiere Arlene A., A phase 2 trial of bortezomib followed by the addition of doxorubicin at progression in patients with recurrent or metastatic adenoid cystic carcinoma of the head and neck : A trial of the eastern cooperative oncology group (E1303), 10.1002/cncr.25852
  30. Anzick Sarah L., Chen Wei-Dong, Park Yoonsoo, Meltzer Paul, Bell Diana, El-Naggar Adel K., Kaye Frederic J., Unfavorable prognosis ofCRTC1-MAML2positive mucoepidermoid tumors withCDKN2Adeletions, 10.1002/gcc.20719
  31. Tirado Yamilet, Williams Michelle D., Hanna Ehab Y., Kaye Frederic J., Batsakis John G., El-Naggar Adel K., CRTC1/MAML2 fusion transcript in high grade mucoepidermoid carcinomas of salivary and thyroid glands and Warthin's tumors: Implications for histogenesis and biologic behavior, 10.1002/gcc.20458
  32. Martins Carmo, Cavaco Branca, Tonon Giovanni, Kaye Frederic J., Soares Jorge, Fonseca Isabel, A Study of MECT1-MAML2 in Mucoepidermoid Carcinoma and Warthin's Tumor of Salivary Glands, 10.1016/s1525-1578(10)60511-9
  33. Behboudi Afrouz, Enlund Fredrik, Winnes Marta, Andrén Ywonne, Nordkvist Anders, Leivo Ilmo, Flaberg Emilie, Szekely Laszlo, Mäkitie Antti, Grenman Reidar, Mark Joachim, Stenman Göran, Molecular classification of mucoepidermoid carcinomas—Prognostic significance of theMECT1–MAML2 fusion oncogene, 10.1002/gcc.20306
  34. Okabe M., MECT1-MAML2 Fusion Transcript Defines a Favorable Subset of Mucoepidermoid Carcinoma, 10.1158/1078-0432.ccr-05-2376
  35. Fehr André, Röser Kerstin, Belge Gazanfer, Löning Thomas, Bullerdiek Jörn, A closer look at Warthin tumors and the t(11;19), 10.1016/j.cancergencyto.2007.10.007
  36. Locati Laura D., Perrone Federica, Losa Marco, Mela Micol, Casieri Paola, Orsenigo Marta, Cortelazzi Barbara, Negri Tiziana, Tamborini Elena, Quattrone Pasquale, Bossi Paolo, Rinaldi Gaetana, Bergamini Cristiana, Calderone Rosa G., Liberatoscioli Cecilia, Licitra Lisa, Treatment relevant target immunophenotyping of 139 salivary gland carcinomas (SGCs), 10.1016/j.oraloncology.2009.05.635
  37. Sequeiros-Santiago, Oncol. Rep., 21, 1215 (2009)
  38. Vidal Laura, Tsao Ming S., Pond Gregory R., Cohen Ezra E. W., Cohen Roger B., Chen Eric X., Agulnik Mark, Hotte Sebastien, Winquist Eric, Laurie Scott, Neil Hayes D., Ho James, Dancey Janet, Siu Lillian L., Fluorescence in situ hybridization gene amplification analysis of EGFR and HER2 in patients with malignant salivary gland tumors treated with lapatinib, 10.1002/hed.21052
  39. Seethala, Arch. Pathol. Lab. Med., 135, 123 (2011)
  40. Vila Lizette, Liu Hongyan, Al-Quran Samer Z, Coco Dominique P, Dong Hui-Jia, Liu Chen, Identification of c-kit gene mutations in primary adenoid cystic carcinoma of the salivary gland, 10.1038/modpathol.2009.95
  41. Negri, Transl. Oncol., 1, 121 (2008)
  42. Seethala Raja R., Dacic Sanja, Cieply Kathleen, Kelly Lindsey M., Nikiforova Marina N., A Reappraisal of the MECT1/MAML2 Translocation in Salivary Mucoepidermoid Carcinomas : , 10.1097/pas.0b013e3181de3021
  43. Persson M., Andren Y., Mark J., Horlings H. M., Persson F., Stenman G., Recurrent fusion of MYB and NFIB transcription factor genes in carcinomas of the breast and head and neck, 10.1073/pnas.0909114106
  44. Mitani Y., Li J., Rao P. H., Zhao Y.-J., Bell D., Lippman S. M., Weber R. S., Caulin C., El-Naggar A. K., Comprehensive Analysis of the MYB-NFIB Gene Fusion in Salivary Adenoid Cystic Carcinoma: Incidence, Variability, and Clinicopathologic Significance, 10.1158/1078-0432.ccr-10-0463
  45. Stenman Goran, Andersson Mattias K., Andren Ywonne, New tricks from an old oncogene : Gene fusion and copy number alterations ofMYBin human cancer, 10.4161/cc.9.15.12515
  46. Dahse Regine, Kromeyer-Hauschild Katrin, Berndt Alexander, Kosmehl Hartwig, No Incidence of BRAF Mutations in Salivary Gland Carcinomas—Implications for Anti-EGFR Therapies, 10.1155/2009/501736
  47. Lujan B, Hakim S, Moyano S, Nadal A, Caballero M, Diaz A, Valera A, Carrera M, Cardesa A, Alos L, Activation of the EGFR/ERK pathway in high-grade mucoepidermoid carcinomas of the salivary glands, 10.1038/sj.bjc.6605788
  48. Press, Cancer Res., 54, 5675 (1994)
  49. Williams M. D., Roberts D. B., Kies M. S., Mao L., Weber R. S., El-Naggar A. K., Genetic and Expression Analysis of HER-2 and EGFR Genes in Salivary Duct Carcinoma: Empirical and Therapeutic Significance, 10.1158/1078-0432.ccr-09-0238
  50. Locati L.D., Bossi P., Perrone F., Potepan P., Crippa F., Mariani L., Casieri P., Orsenigo M., Losa M., Bergamini C., Liberatoscioli C., Quattrone P., Calderone R.G., Rinaldi G., Pilotti S., Licitra L., Cetuximab in recurrent and/or metastatic salivary gland carcinomas: A phase II study, 10.1016/j.oraloncology.2008.07.010
  51. Glisson B. S., Blumenschein G., Francisco M., Erasmus J., Zinner R., Kies M., Phase II trial of gefitinib in patients with incurable salivary gland cancer, 10.1200/jco.2005.23.16_suppl.5532
  52. Agulnik Mark, Cohen Ezra W.E., Cohen Roger B., Chen Eric X., Vokes Everett E., Hotte Sebastien J., Winquist Eric, Laurie Scott, Hayes D. Neil, Dancey Janet E., Brown Shirley, Pond Gregory R., Lorimer Ian, Daneshmand Manijeh, Ho James, Tsao Ming-Sound, Siu Lillian L., Phase II Study of Lapatinib in Recurrent or Metastatic Epidermal Growth Factor Receptor and/or erbB2 Expressing Adenoid Cystic Carcinoma and Non–Adenoid Cystic Carcinoma Malignant Tumors of the Salivary Glands, 10.1200/jco.2007.11.8612
  53. Hotte Sébastien J., Winquist Eric W., Lamont Elizabeth, MacKenzie Mary, Vokes Everett, Chen Eric X., Brown Shirley, Pond Gregory R., Murgo Anthony, Siu Lillian L., Imatinib Mesylate in Patients With Adenoid Cystic Cancers of the Salivary Glands Expressing c-kit: A Princess Margaret Hospital Phase II Consortium Study, 10.1200/jco.2005.06.125
  54. Pfeffer M. Raphael, Talmi Yoav, Catane Raphael, Symon Zvi, Yosepovitch Ady, Levitt Mark, A phase II study of Imatinib for advanced adenoid cystic carcinoma of head and neck salivary glands, 10.1016/j.oraloncology.2005.12.026